Theralase targets up to C$5 million in brokered private placement at C$0.24 per unit

Reuters2026/08/10 21:16

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Theralase launched a brokered LIFE private placement of units at C$ 0.24 to raise C$ 3 million to C$ 5 million.
Each unit includes 1 common share, 1 warrant exercisable at C$ 0.32 until May 20, 2031.
Proceeds earmarked for GLP toxicology work supporting clinical development of Rutherrin intravenous cancer program, Ruvidar topical cold sore program, working capital.
Research Capital to act as sole agent; offering size can increase by up to 15% via an over-allotment option.
Closing targeted for Aug. 24, 2026, subject to TSXV approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theralase Technologies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608101715NEWSFILECNPR____20260810_309076_1) on August 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Theralase targets up to C$5 million in brokered private placement at C$0.24 per unit

You may also like

Crypto prices